Samsara BioCapital GP, LLC
SEC insider (Form 3/4/5 filer). CIK 0001888829. 10% Owner at Kalaris Therapeutics, Inc. (KLRS) and 3 other issuers. 7 reported Form 4/5 transactions since Sep 2024; latest on Mar 13, 2025. Located in PALO ALTO, CA.
Companies Samsara BioCapital GP, LLC has filed insider reports for
- Kalaris Therapeutics, Inc. (KLRS): 10% Owner
- Mineralys Therapeutics, Inc. (MLYS): 10% Owner
- vTv Therapeutics Inc. (VTVT): 10% Owner
- Neurogene Inc. (NGNE): 10% Owner
Samsara BioCapital GP, LLC
CIK: 0001888829
Transaction Breakdown
Open Market Buys (P)5 (71.4%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (14.3%)
Compensation grants
Other (G, F, J, C, D, …)1 (14.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Mar 13, 2025MLYS
Mineralys Therapeutics, Inc.
PurchaseIndirect600K shares at avg. $13.50$8.1M - Nov 26, 2024NGNE
Neurogene Inc.
PurchaseIndirect20.7K shares at avg. $24.91$517K - Nov 26, 2024NGNE
Neurogene Inc.
PurchaseIndirect10.8K shares at avg. $26.01$281K - Nov 26, 2024NGNE
Neurogene Inc.
PurchaseIndirect15.2K shares at avg. $26.73$407K - Nov 26, 2024NGNE
Neurogene Inc.
PurchaseIndirect2K shares at avg. $27.50$55K - Mar 5, 2024VTVT
vTv Therapeutics Inc.
OtherIndirect58.8K shares- - Mar 5, 2024VTVT
vTv Therapeutics Inc.
AwardIndirectPre- Funded Warrants (Right to Buy)
58.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 13, 2025 |  MLYS Mineralys Therapeutics, Inc. | Purchase | 600,000 | $13.50 | $8,100,000 | Indirect |
| Nov 26, 2024 |  NGNE Neurogene Inc. | Purchase | 20,748 | $24.91 | $516,833 | Indirect |
| Nov 26, 2024 | NGNE Neurogene Inc. | Purchase | 10,803 | $26.01 | $280,986 | Indirect |
| Nov 26, 2024 | NGNE Neurogene Inc. | Purchase | 15,219 | $26.73 | $406,804 | Indirect |
| Nov 26, 2024 | NGNE Neurogene Inc. | Purchase | 2,000 | $27.50 | $55,000 | Indirect |
| Mar 5, 2024 |  VTVT vTv Therapeutics Inc. | Other | 58,836 | - | $0 | Indirect |
| Mar 5, 2024 | VTVT vTv Therapeutics Inc. | Award Pre- Funded Warrants (Right to Buy) | 58,885 | - | - | Indirect |
1-7 of 7 transactions